UFF
BIO icon

USA Financial Formulas’s Bio-Rad Laboratories Class A BIO Stock Holding History

USA Financial Formulas’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed -$1K – 340
2020
Q4 		$1K Sell
2
-1,917
-100% -$1.09M ﹤0.01% 254
2020
Q3 		$989K Buy
1,919
+1,182
+160% +$599K 0.75% 53
2020
Q2 		$333K Buy
+737
New +$325K 0.25% 64
2017
Q3 		– Sell
-3,455
Closed -$782K – 254
2017
Q2 		$782K Buy
+3,455
New +$753K 0.19% 110

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

USA Financial Formulas's BIO Position: Q1 2021 in Review

USA Financial Formulas sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2021, closing a stake of 2 shares — an estimated $1K sold.

USA Financial Formulas first reported a position in BIO in Q2 2017 and held it in 4 quarters. The position peaked at $989K in Q3 2020. 491 funds tracked by Wall St. Rank hold BIO as of Q1 2021.

  • USA Financial Formulas reported no remaining Bio-Rad Laboratories Class A position as of Q1 2021 after selling out during the quarter.
  • USA Financial Formulas sold 2 Bio-Rad Laboratories Class A shares in Q1 2021, an estimated $1K.
  • USA Financial Formulas first reported a position in Bio-Rad Laboratories Class A in Q2 2017 and held it in 4 quarters.
  • USA Financial Formulas's Bio-Rad Laboratories Class A position peaked at $989K in Q3 2020.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2021.

Based on USA Financial Formulas's 13F filing for Q1 2021, filed 6 May 2021.